Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment

References

• Soriano JB, Alfageme I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021;57:61–69. doi:10.1016/j.arbres.2020.07.024
   PubMed Web of Science ®Google Scholar
• Momtazmanesh S, Moghaddam SS, Ghamari S-H; Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the global burden of disease study 2019. EClinicalMedicine. 2023;59:101936. doi:10.1016/j.eclinm.2023.101936
   PubMedGoogle Scholar
• Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320:2461–2473. doi:10.1001/jama.2018.19271
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Vrijens B, Dima AL, Van Ganse E, et al. what we mean when we talk about adherence in respiratory medicine. J Allergy Clin Immunol Pract. 2016;4:802–812. doi:10.1016/j.jaip.2016.05.019
   PubMed Web of Science ®Google Scholar
• Epping-Jordan J, Bengoa R, Kawar R, Sabaté E. The challenge of chronic conditions: WHO responds. BMJ. 2001;323:947–948. doi:10.1136/bmj.323.7319.947
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Biddiscombe MF, Usmani OS. Is there room for further innovation in inhaled therapy for airways disease? Breathe. 2018;14:216–224. doi:10.1183/20734735.020318
   Web of Science ®Google Scholar
• Honkoop P, Usmani O, Bonini M. The current and future role of technology in respiratory care. Pulm Ther. 2022;8:167–179. doi:10.1007/s41030-022-00191-y
   PubMedGoogle Scholar
• Vestbo J, Anderson JA, Calverley PMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939–943. doi:10.1136/thx.2009.113662
   PubMed Web of Science ®Google Scholar
• Romagnoli A, Santoleri F, Costantini A. Adherence and persistence analysis after three years in real-life of inhalation therapies used in the treatment of COPD. Curr Med Res Opin. 2020;36:2055–2061. doi:10.1080/03007995.2020.1841617
   PubMed Web of Science ®Google Scholar
• Deslee G, Fabry-Vendrand C, Poccardi N, et al. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study). BMJ Open Respir Res. 2023;10:e001585. doi:10.1136/bmjresp-2022-001585
   PubMed Web of Science ®Google Scholar
• Mueller S, Wilke T, Bechtel B, Punekar YS, Mitzner K, Virchow JC. Non-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims dataset. Respir Med. 2017;122:1–11. doi:10.1016/j.rmed.2016.11.008
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Rothnie KJ, Banks V, et al. comparative adherence and persistence of single- and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in an English real-world primary care setting. Int J Chron Obstruct Pulmon Dis. 2022;17:2417–2429. doi:10.2147/COPD.S370540
   PubMed Web of Science ®Google Scholar
• Alcázar-Navarrete B, Jamart L, Sánchez-Covisa J, Juárez M, Graefenhain R, Sicras-Mainar A. Clinical characteristics, treatment persistence, and outcomes among patients with COPD treated with single- or multiple-inhaler triple therapy: a retrospective analysis in Spain. Chest. 2022;162:1017–1029. doi:10.1016/j.chest.2022.06.033
   PubMed Web of Science ®Google Scholar
• van Boven JFM, Chavannes NH, van der Molen T, Rutten-van MMPMH, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108:103–113. doi:10.1016/j.rmed.2013.08.044
   PubMed Web of Science ®Google Scholar
• Ágh T, Inotai A, Mészáros Á. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011;82:328–334. doi:10.1159/000324453
   PubMed Web of Science ®Google Scholar
• Polański J, Chabowski M, Świątoniowska-Lonc N, Mazur G, Jankowska-Polańska B. Medication compliance in COPD patients. Adv Exp Med Biol. 2020;1279:81–91.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: myth and reality. Respir Med. 2017;129:117–123. doi:10.1016/j.rmed.2017.06.007
   PubMed Web of Science ®Google Scholar
• Sulaiman I, Cushen B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195:1333–1343. doi:10.1164/rccm.201604-0733OC
   PubMed Web of Science ®Google Scholar
• Albrecht JS, Park Y, Hur P, et al. Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease. The role of depression. Ann Am Thorac Soc. 2016;13:1497–1504. doi:10.1513/AnnalsATS.201602-136OC
   PubMed Web of Science ®Google Scholar
• Plaza V, Fernández-Rodríguez C, Melero C, et al. Validation of the “Test of the Adherence to Inhalers” (TAI) for asthma and COPD patients. J Aerosol Med Pulm Drug Deliv. 2016;29:142–152. doi:10.1089/jamp.2015.1212
   PubMed Web of Science ®Google Scholar
• Plaza V, López-Viña A, Entrenas LM, et al. Differences in adherence and non-adherence behaviour patterns to inhaler devices between and asthma patients. COPD. 2016;13:547–554. doi:10.3109/15412555.2015.1118449
   PubMedGoogle Scholar
• Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: gold executive summary. Arch Bronconeumol. 2023;59:232–248. doi:10.1016/j.arbres.2023.02.009
   PubMed Web of Science ®Google Scholar
• Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2021;9:CD013381. doi:10.1002/14651858.CD013381.pub2
   PubMedGoogle Scholar
• Zabczyk C, Blakey JD. The effect of connected “smart. Inhalers Med Adherence Front Med Technol. 2021;3:657321. doi:10.3389/fmedt.2021.657321
   PubMedGoogle Scholar
• López-Campos JL, Quintana Gallego E, Carrasco Hernández L. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503–1515. doi:10.2147/COPD.S170848
   PubMed Web of Science ®Google Scholar
• Criner GJ, Cole T, Hahn KA, Kastango K, Eudicone J, Gilbert I. The impact of budesonide/formoterol pmdi medication reminders on adherence in chronic obstructive pulmonary disease (COPD) patients: results of a randomized, phase 4, clinical study. Int J Chron Obstruct Pulmon Dis. 2021;16:563–577. doi:10.2147/COPD.S253770
   PubMed Web of Science ®Google Scholar
• Stanford RH, Averell CM, Johnson PT, Buysman EK, Carlyle MH. Adherence and usage patterns of inhaled corticosteroids-long-acting beta-agonists by using inhaler-monitoring technology. Allergy Asthma Proc. 2020;41:256–264. doi:10.2500/aap.2020.41.200037
   PubMed Web of Science ®Google Scholar
• Agustí A, de Teresa L, De Backer W, et al. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. Eur Respir J. 2014;43:763–772. doi:10.1183/09031936.00054213
   PubMed Web of Science ®Google Scholar
• Stanford RH, Parker ED, Reinsch TK, Buikema AR, Blauer-Peterson C. Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA. Respir Med. 2019;150:1–7. doi:10.1016/j.rmed.2019.01.019
   PubMed Web of Science ®Google Scholar
• Mannino D, Bogart M, Wu B, et al. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: a real-world study. Respir Med. 2022;197:106807. doi:10.1016/j.rmed.2022.106807
   PubMed Web of Science ®Google Scholar
• Price D, Lee AJ, Sims EJ, et al. Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study. Prim Care Respir J. 2013;22:161–168. doi:10.4104/pcrj.2013.00017
   PubMedGoogle Scholar
• Toy EL, Beaulieu NU, McHale JM, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105:435–441. doi:10.1016/j.rmed.2010.09.006
   PubMed Web of Science ®Google Scholar
• Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidiscip Respir Med. 2014;9:60. doi:10.1186/2049-6958-9-60
   PubMedGoogle Scholar
• Izquierdo JL, Paredero JM, Piedra R. Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:289–293. doi:10.2147/COPD.S96948
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Worsley S, Ismaila AS, et al. INTREPID: single-versus multiple-inhaler triple therapy for COPD in usual clinical practice. ERJ Open Res. 2021;7:00950–2020. doi:10.1183/23120541.00950-2020
   PubMedGoogle Scholar
• Plaza V, Giner J, Rodrigo GJ, Dolovich MB, Sanchis J. Errors in the use of inhalers by health care professionals: a systematic review. J Allergy Clin Immunol Pract. 2018;6:987–995. doi:10.1016/j.jaip.2017.12.032
   PubMed Web of Science ®Google Scholar
• Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108: 358–65
   PubMed Web of Science ®Google Scholar
• Bosnic-Anticevich S, Chrystyn H, Costello RW, et al. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes. Int J Chron Obstruct Pulmon Dis. 2017;12:59–71. doi:10.2147/COPD.S117196
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Alcázar B, Viejo JL. Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. results of epoca delphi consensus. Pulm Pharmacol Ther. 2018;48. doi:10.1016/j.pupt.2018.06.004
   PubMed Web of Science ®Google Scholar
• García-Río F, Soler-Cataluña JJ, Alcazar B, Viejo JL, Miravitlles M. Requirements strengths and weaknesses of inhaler devices for COPD patients from the expert prescribers’ point of view: results of the epoca delphi Consensus. COPD. 2017;14:573–580. doi:10.1080/15412555.2017.1365120
   PubMedGoogle Scholar
• Peché R, Attar-Zadeh D, Scullion J, Kocks J, Winocur E, Sarig R. Matching the inhaler to the patient in COPD. J Clin Med. 2021;11:10. doi:10.3390/jcm11010010
   PubMedGoogle Scholar
• Miravitlles M, Marín A, Huerta A, Carcedo D, Villacampa A, Puig-Junoy J. Estimation of the clinical and economic impact of an improvement in adherence based on the use of once-daily single-inhaler triple therapy in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:1643–1654. doi:10.2147/COPD.S253567
   PubMed Web of Science ®Google Scholar